We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As with all clinical trials, the MHRA’s top priority is the safety and wellbeing of the trial participants.
Switching the NHS vehicle fleet to electric will save the health service millions and help to decarbonise 460 million miles of travel each year.
UKHSA data shows that fewer than half take up the free shingles jab.
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
The MHRA invited the next generation of doctors to explore how genetics could improve prescribing and patient safety in the UK.
Patients will receive better support to help them stay in and get back to work in areas of high economic inactivity.
Officers from the MHRA's Criminal Enforcement Unit (CEU) have raided two separate premises as part of an ongoing investigation into an organised criminal network involved in the manufacture and sale of unlicensed weight …
Fake medicines are illegally produced products that may contain incorrect ingredients, no active ingredients, or harmful substances.
As with any medicine, the MHRA will keep the safety and effectiveness of imlunestrant tosylate under close review.
Patients to benefit from improved access to GP appointments under new contract backed by nearly £500 million.
By Richard Stubbs
The 12-week public consultation that opened on Friday 28 November 2025 has closed.
This response agrees with recommendations from the Advisory Council on the Misuse of Drugs (ACMD) in 3 reports about the control and scheduling of 5 medicines.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about the consideration of ganaxolone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about zuranolone.
Letter from the Advisory Council on the Misuse of Drugs (ACMD) to the Minister for Policing and Crime Prevention, about 3 growth hormone agonists.
As with any medicine, the MHRA will keep the safety and effectiveness of brensocatib under close review.
New changes to the GP contract will help protect thousands more children across the country from deadly and highly infectious diseases.
Patients across the country will have better access to NHS dentistry, boosting earlier intervention, prevention and continuity of care.
MHRA has raised new concerns around the PATHWAYS trial looking into the prescription of puberty blockers among young people with gender incongruence.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).